DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY

Evan S. Dellon  ¹     Marc E. Rothenberg  ²     Margaret H. Collins     Ikuo Hirano  ³     Mirna Chehade  ⁴     Arjan Bredenoord  ⁵     Alfredo J. Lucendo  ⁶     Jonathan M. Spergel  ⁷     Xian Sun  ⁸     Jennifer D. Hamilton     Eric Mortensen     Elizabeth Laws  ⁹     Jennifer Maloney     Lila Glotfelty     Arsalan Shabbir    
¹ University of North Carolina School of Medicine, Chapel Hill, United States
² Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, United States
³ Northwestern University Feinberg School of Medicine, Chicago, United States
⁴ Mount Sinai Center for Eosinophilic Disorders, New York, United States
⁵ Amsterdam University Medical Centers, Amsterdam, Netherlands
⁶ Hospital General de Tomelloso, Tomelloso, Spain
⁷ Children's Hospital of Philadelphia, Philadelphia, United States
⁸ Regeneron Pharmaceuticals Inc., Tarrytown, United States
⁹ Sanofi, Bridgewater, United States

Topic
Oesophagus, Paediatrics

Session
What is the best recipe for EoE: PPI, steroids or monochrome?

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)